Answers are grounded in this paper and cite their sources.
Frontal fibrosing alopecia (FFA) is a progressive cicatricial alopecia that can affect patients with skin of color (SOC); however, patients with SOC often are underrepresented in clinical trials and scientific publications on FFA.To better understand the management of FFA in patients with SOC, we sought to assess the clinical evidence for the efficacy of FFA treatment modalities specifically in these patients.This systematic review discusses studies on FFA characteristics and treatment outcomes in Black patients.Cutis.2023;111:186-190, E1-E2. Frontal fibrosing alopecia (FFA) is a lymphocytic cicatricial alopecia that primarily affects postmenopausal women.Considered a subtype of lichen planopilaris (LPP), FFA is histologically identical but presents as symmetric frontotemporal hairline recession rather than the multifocal distribution typical of LPP (Figure 1).Patients also may experience symptoms such as itching, facial papules, and eyebrow loss.As a progressive and scarring alopecia, early management of FFA is necessary to prevent permanent hair loss; however, there still are no clear guidelines regarding the efficacy of different treatment options for FFA due to a lack of randomized controlled studies in the literature.Patients with skin of color (SOC) also may have varying responses to treatment, further complicating the establishment of any treatment algorithm.Furthermore, symptoms, clinical findings, and demographics of FFA have been observed to vary across different ethnicities, especially among Black individuals.We conducted a systematic review of the literature on FFA in Black patients, with an analysis of demographics, clinical findings, concomitant skin conditions, treatments given, and treatment responses. MethodsA PubMed search of articles indexed for MEDLINE was conducted of studies investigating FFA in patients with SOC from January 1, 2000, through November 30, 2020, using the terms frontal fibrosing alopecia, ethnicity, African, Black, Asian, Indian, Hispanic, and Latino.Articles were included if they were available in English and discussed treatment and clinical outcomes of FFA in Black individuals.The reference lists of included studies also were reviewed.Articles were assessed for quality of evidence using a 4-point scale (1=well-designed randomized controlled trials; 2=controlled trials with limitations or welldesigned cohort or case-control studies; 3=case series with or without intervention; 4=case reports).Variables related to study type, patient demographics, treatments, and clinical outcomes were recorded.
No takes yet. Share an insight, caveat, or question.
Josephine Hai (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: